LTA anticorps

N° du produit ABIN7240307

Détail du produit anti-LTA anticorps

Antigène: LTA (Lymphotoxin-alpha (LTA))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LTA est non-conjugé

Application: ELISA, Immunohistochemistry (IHC)

Attributs du produit: Polyclonal Antibody

Purification: Affinity purification

Immunogène: Recombinant protein of human LTA

Isotype: IgG

Information d'application

Indications d'application: IHC 1:50-1:200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur LTA

Antigène: LTA (Lymphotoxin-alpha (LTA))

Autre désignation: TNF beta (LTA Produits)

Synonymes: anticorps LT, anticorps TNFB, anticorps TNFSF1, anticorps LT-[a], anticorps LT-alpha, anticorps LT[a], anticorps LTalpha, anticorps Ltx, anticorps TNF-beta, anticorps Tnfb, anticorps Tnfsf1b, anticorps hlb382, anticorps lymphotoxin alpha, anticorps lymphotoxin A, anticorps LTA, anticorps Lta

Classe de substances: Chemical

Sujet: The encoded protein, a member of the tumor necrosis factor family, is a cytokine produced by lymphocytes. The protein is highly inducible, secreted, and forms heterotrimers with lymphotoxin-beta which anchor lymphotoxin-alpha to the cell surface. This protein also mediates a large variety of inflammatory, immunostimulatory, and antiviral responses, is involved in the formation of secondary lymphoid organs during development and plays a role in apoptosis. Genetic variations in this gene are associated with susceptibility to leprosy type 4, myocardial infarction, non-Hodgkin's lymphoma, and psoriatic arthritis. Alternatively spliced transcript variants have been observed for this gene.

UniProt: P01374

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process